The present invention relates to a combination comprising (a) an adenosine A_2a receptor agonist as defined herein and (b) an adrenergic 2 receptor agonist, for simultaneous, sequential or separate administration by the inhaled route in the treatment of an obstructive airways or other inflammatory disease.